 | • レポートコード：MRC2102QY2697 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のセレコキシブ市場について種類別（50mg、100mg、200mg、400mg）、用途別（関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他気）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・セレコキシブ市場の概要 ・世界の主要地域別セレコキシブ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のセレコキシブ市場規模2015-2026：種類別（50mg、100mg、200mg、400mg） ・世界のセレコキシブ市場規模2015-2026：用途別（関節リウマチ、変形性関節症、急性痛、筋骨格痛、その他気） ・セレコキシブの米国市場規模2015-2020 ・セレコキシブのヨーロッパ市場規模2015-2020 ・セレコキシブの中国市場規模2015-2020 ・セレコキシブの日本市場規模2015-2020 ・セレコキシブの東南アジア市場規模2015-2020 ・セレコキシブのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・セレコキシブの製造コスト分析 ・販売チャネル、流通業者、顧客 ・セレコキシブの市場動向・機会・課題 ・調査の結論 |
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
Market Analysis and Insights: Global Celecoxib Market
The global Celecoxib market size is projected to reach US$ 1902.8 million by 2026, from US$ 1175.4 million in 2020, at a CAGR of 8.4% during 2021-2026.
Global Celecoxib Scope and Market Size
The global Celecoxib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Celecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Celecoxib market is segmented into
50mg
100mg
200mg
400mg
Segment by Application, the Celecoxib market is segmented into
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
The Celecoxib market is analysed and market size information is provided by regions (countries). Segment by Application, the Celecoxib market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Celecoxib Market Share Analysis
Celecoxib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Celecoxib business, the date to enter into the Celecoxib market, Celecoxib product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
1 Celecoxib Market Overview
1.1 Celecoxib Product Scope
1.2 Celecoxib Segment by Type
1.2.1 Global Celecoxib Sales by Type (2020-2026)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib Segment by Application
1.3.1 Global Celecoxib Sales Comparison by Application (2020-2026)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Celecoxib Market Estimates and Forecasts (2015-2026)
1.4.1 Global Celecoxib Sales Growth Rate (2015-2026)
1.4.2 Global Celecoxib Revenue and Growth Rate (2015-2026)
1.4.3 Global Celecoxib Price Trends (2015-2026)
2 Celecoxib Estimate and Forecast by Region
2.1 Global Celecoxib Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Celecoxib Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Celecoxib Sales Market Share by Region (2015-2020)
2.2.2 Global Celecoxib Revenue Market Share by Region (2015-2020)
2.3 Global Celecoxib Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Celecoxib Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Celecoxib Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Celecoxib Estimates and Projections (2015-2026)
2.4.2 Europe Celecoxib Estimates and Projections (2015-2026)
2.4.3 China Celecoxib Estimates and Projections (2015-2026)
2.4.4 Japan Celecoxib Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Celecoxib Estimates and Projections (2015-2026)
2.4.6 India Celecoxib Estimates and Projections (2015-2026)
3 Global Celecoxib Competition Landscape by Players
3.1 Global Top Celecoxib Players by Sales (2015-2020)
3.2 Global Top Celecoxib Players by Revenue (2015-2020)
3.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celecoxib as of 2019)
3.4 Global Celecoxib Average Price by Company (2015-2020)
3.5 Manufacturers Celecoxib Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Celecoxib Players (Opinion Leaders)
4 Global Celecoxib Market Size by Type
4.1 Global Celecoxib Historic Market Review by Type (2015-2020)
4.1.1 Global Celecoxib Sales Market Share by Type (2015-2020)
4.1.2 Global Celecoxib Revenue Market Share by Type (2015-2020)
4.1.3 Global Celecoxib Price by Type (2015-2020)
4.2 Global Celecoxib Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Celecoxib Sales Forecast by Type (2021-2026)
4.2.2 Global Celecoxib Revenue Forecast by Type (2021-2026)
4.2.3 Global Celecoxib Price Forecast by Type (2021-2026)
5 Global Celecoxib Market Size by Application
5.1 Global Celecoxib Historic Market Review by Application (2015-2020)
5.1.1 Global Celecoxib Sales Market Share by Application (2015-2020)
5.1.2 Global Celecoxib Revenue Market Share by Application (2015-2020)
5.1.3 Global Celecoxib Price by Application (2015-2020)
5.2 Global Celecoxib Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Celecoxib Sales Forecast by Application (2021-2026)
5.2.2 Global Celecoxib Revenue Forecast by Application (2021-2026)
5.2.3 Global Celecoxib Price Forecast by Application (2021-2026)
6 United States Celecoxib Market Facts & Figures
6.1 United States Celecoxib Sales Market Share by Company (2015-2020)
6.2 United States Celecoxib Sales Market Share by Type (2015-2020)
6.3 United States Celecoxib Sales Market Share by Application (2015-2020)
7 Europe Celecoxib Market Facts & Figures
7.1 Europe Celecoxib Sales Market Share by Company (2015-2020)
7.2 Europe Celecoxib Sales Market Share by Type (2015-2020)
7.3 Europe Celecoxib Sales Market Share by Application (2015-2020)
8 China Celecoxib Market Facts & Figures
8.1 China Celecoxib Sales Market Share by Company (2015-2020)
8.2 China Celecoxib Sales Market Share by Type (2015-2020)
8.3 China Celecoxib Sales Market Share by Application (2015-2020)
9 Japan Celecoxib Market Facts & Figures
9.1 Japan Celecoxib Sales Market Share by Company (3015-3030)
9.2 Japan Celecoxib Sales Market Share by Type (2015-2020)
9.3 Japan Celecoxib Sales Market Share by Application (2015-2020)
10 Southeast Asia Celecoxib Market Facts & Figures
10.1 Southeast Asia Celecoxib Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Celecoxib Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Celecoxib Sales Market Share by Application (2015-2020)
11 India Celecoxib Market Facts & Figures
11.1 India Celecoxib Sales Market Share by Company (2015-2020)
11.2 India Celecoxib Sales Market Share by Type (2015-2020)
11.3 India Celecoxib Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Celecoxib Business
12.1 Pfizer Inc
12.1.1 Pfizer Inc Corporation Information
12.1.2 Pfizer Inc Business Overview
12.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc Celecoxib Products Offered
12.1.5 Pfizer Inc Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Celecoxib Products Offered
12.2.5 Teva Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mylan Celecoxib Products Offered
12.3.5 Mylan Recent Development
12.4 Apotex
12.4.1 Apotex Corporation Information
12.4.2 Apotex Business Overview
12.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Apotex Celecoxib Products Offered
12.4.5 Apotex Recent Development
12.5 Lupin
12.5.1 Lupin Corporation Information
12.5.2 Lupin Business Overview
12.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lupin Celecoxib Products Offered
12.5.5 Lupin Recent Development
12.6 Hengrui Medicine
12.6.1 Hengrui Medicine Corporation Information
12.6.2 Hengrui Medicine Business Overview
12.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Hengrui Medicine Celecoxib Products Offered
12.6.5 Hengrui Medicine Recent Development
…
13 Celecoxib Manufacturing Cost Analysis
13.1 Celecoxib Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Celecoxib
13.4 Celecoxib Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Celecoxib Distributors List
14.3 Celecoxib Customers
15 Market Dynamics
15.1 Celecoxib Market Trends
15.2 Celecoxib Opportunities and Drivers
15.3 Celecoxib Market Challenges
15.4 Celecoxib Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Celecoxib Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Celecoxib Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Celecoxib Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Celecoxib Sales (K Units) by Region (2015-2020)
Table 5. Global Celecoxib Sales Market Share by Region (2015-2020)
Table 6. Global Celecoxib Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Celecoxib Revenue Share by Region (2015-2020)
Table 8. Global Celecoxib Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Celecoxib Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Celecoxib Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Celecoxib Revenue Share Forecast by Region (2021-2026)
Table 12. Global Celecoxib (K Units) of Key Companies (2015-2020)
Table 13. Global Celecoxib Sales Share by Company (2015-2020)
Table 14. Global Celecoxib Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Celecoxib Revenue Share by Company (2015-2020)
Table 16. Global Celecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celecoxib as of 2019)
Table 17. Global Celecoxib Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Celecoxib Manufacturing Sites and Area Served
Table 19. Manufacturers Celecoxib Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Celecoxib Players
Table 22. Global Celecoxib Sales (K Units) by Type (2015-2020)
Table 23. Global Celecoxib Sales Share by Type (2015-2020)
Table 24. Global Celecoxib Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Celecoxib Price (K Units) by Type (2015-2020)
Table 26. Global Celecoxib Sales Share by Type (2021-2026)
Table 27. Global Celecoxib Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Celecoxib Revenue Share by Type (2021-2026)
Table 29. Global Celecoxib Price (K Units) by Type (2021-2026)
Table 30. Global Celecoxib Sales (K Units) by Application (2015-2020)
Table 31. Global Celecoxib Sales Share by Application (2015-2020)
Table 32. Global Celecoxib Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Celecoxib Price (K Units) by Application (2015-2020)
Table 34. Global Celecoxib Sales (K Units) by Application (2021-2026)
Table 35. Global Celecoxib Sales Share by Application (2021-2026)
Table 36. Global Celecoxib Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Celecoxib Revenue Share by Application (2021-2026)
Table 38. Global Celecoxib Price (K Units) by Application (2021-2026)
Table 39. United States Celecoxib Sales (K Units) by Company (2015-2020)
Table 40. United States Celecoxib Sales Market Share by Company (2015-2020)
Table 41. United States Celecoxib Sales (K Units) by Type (2015-2020)
Table 42. United States Celecoxib Sales Market Share by Type (2015-2020)
Table 43. United States Celecoxib Sales (K Units) by Application (2015-2020)
Table 44. United States Celecoxib Sales Market Share by Application (2015-2020)
Table 45. Europe Celecoxib Sales (K Units) by Company (2015-2020)
Table 46. Europe Celecoxib Sales Market Share by Company (2015-2020)
Table 47. Europe Celecoxib Sales (K Units) by Type (2015-2020)
Table 48. Europe Celecoxib Sales Market Share by Type (2015-2020)
Table 49. Europe Celecoxib Sales (K Units) by Application (2015-2020)
Table 50. Europe Celecoxib Sales Market Share by Type (2015-2020)
Table 51. China Celecoxib Sales (K Units) by Company (2015-2020)
Table 52. China Celecoxib Sales Market Share by Company (2015-2020)
Table 53. China Celecoxib Sales (K Units) by Type (2015-2020)
Table 54. China Celecoxib Sales Market Share by Type (2015-2020)
Table 55. China Celecoxib Sales (K Units) by Application (2015-2020)
Table 56. China Celecoxib Sales Market Share by Application (2015-2020)
Table 57. Japan Celecoxib Sales (K Units) by Company (2015-2020)
Table 58. Japan Celecoxib Sales Market Share by Company (2015-2020)
Table 59. Japan Celecoxib Sales (K Units) by Type (2015-2020)
Table 60. Japan Celecoxib Sales Market Share by Type (2015-2020)
Table 61. Japan Celecoxib Sales (K Units) by Application (2015-2020)
Table 62. Japan Celecoxib Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Celecoxib Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Celecoxib Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Celecoxib Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Celecoxib Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Celecoxib Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Celecoxib Sales Market Share by Application (2015-2020)
Table 69. India Celecoxib Sales (K Units) by Company (2015-2020)
Table 70. India Celecoxib Sales Market Share by Company (2015-2020)
Table 71. India Celecoxib Sales (K Units) by Type (2015-2020)
Table 72. India Celecoxib Sales Market Share by Type (2015-2020)
Table 73. India Celecoxib Sales (K Units) by Application (2015-2020)
Table 74. India Celecoxib Sales Market Share by Application (2015-2020)
Table 75. Pfizer Inc Corporation Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Inc Celecoxib Product
Table 79. Pfizer Inc Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Teva Celecoxib Product
Table 84. Teva Recent Development
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Mylan Celecoxib Product
Table 89. Mylan Recent Development
Table 90. Apotex Corporation Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Apotex Celecoxib Product
Table 94. Apotex Recent Development
Table 95. Lupin Corporation Information
Table 96. Lupin Description and Business Overview
Table 97. Lupin Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Lupin Celecoxib Product
Table 99. Lupin Recent Development
Table 100. Hengrui Medicine Corporation Information
Table 101. Hengrui Medicine Description and Business Overview
Table 102. Hengrui Medicine Celecoxib Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. Hengrui Medicine Celecoxib Product
Table 104. Hengrui Medicine Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Celecoxib Distributors List
Table 108. Celecoxib Customers List
Table 109. Celecoxib Market Key Trends
Table 110. Celecoxib Key Opportunities and Drivers
Table 111. Celecoxib Market Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Celecoxib Product Picture
Figure 2. Global Celecoxib Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Celecoxib Market Share by Application in 2020 & 2026
Figure 6. Rheumatoid arthritis Examples
Figure 7. osteoarthritis Examples
Figure 8. Acute pain Examples
Figure 9. Musculoskeletal pain Examples
Figure 10. Other diseases Examples
Figure 11. Global Celecoxib Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Celecoxib Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Celecoxib Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 14. Global Celecoxib Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Celecoxib Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Celecoxib Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Celecoxib Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Celecoxib Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Celecoxib Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Celecoxib Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Celecoxib Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Celecoxib Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Celecoxib Players Market Share by Revenue in Celecoxib 2015 & 2019
Figure 29. Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Celecoxib Revenue Share by Type (2015-2020)
Figure 31. Global Celecoxib Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Celecoxib Revenue Share by Application (2015-2020)
Figure 33. Global Celecoxib Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Celecoxib Sales Market Share by Type in 2019
Figure 35. United States Celecoxib Sales Market Share by Type in 2019
Figure 36. Europe Celecoxib Sales Market Share by Company in 2019
Figure 37. Europe Celecoxib Sales Market Share by Type in 2019
Figure 38. Europe Celecoxib Sales Market Share by Application in 2019
Figure 39. China Celecoxib Sales Market Share by Company in 2019
Figure 40. China Celecoxib Sales Market Share by Type in 2019
Figure 41. China Celecoxib Sales Market Share by Application in 2019
Figure 42. Japan Celecoxib Sales Market Share by Company in 2019
Figure 43. Japan Celecoxib Sales Market Share by Type in 2019
Figure 44. Japan Celecoxib Sales Market Share by Application in 2019
Figure 45. Southeast Asia Celecoxib Sales Market Share by Company in 2019
Figure 46. Southeast Asia Celecoxib Sales Market Share by Type in 2019
Figure 47. Southeast Asia Celecoxib Sales Market Share by Application in 2019
Figure 48. India Celecoxib Sales Market Share by Company in 2019
Figure 49. India Celecoxib Sales Market Share by Type in 2019
Figure 50. India Celecoxib Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Celecoxib
Figure 53. Manufacturing Process Analysis of Celecoxib
Figure 54. Celecoxib Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
疼痛管理薬・デバイスの世界市場レポート2020 Market Analysis and Insights: Global Pain Management Drugs & Devices Market The global Pain Management Drugs & Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pain Management Drugs & Devices Scope and Market Siz…- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …
- 疼痛管理用高周波焼灼装置の世界市場レポート2020 Market Analysis and Insights: Global Radiofrequency Ablation Devices for Pain Management Market The global Radiofrequency Ablation Devices for Pain Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Radiofrequen…
- 非オピオイド疼痛パッチの世界市場レポート2020 Market Analysis and Insights: Global Non-opioid Pain Patch Market The global Non-opioid Pain Patch market size is projected to reach US$ 759.7 million by 2026, from US$ 650.9 million in 2020, at a CAGR of 2.6% during 2021-2026. Global Non-opioid Pain Patch Scope and Market Size The global Non-opioid…
- 亜急性期用人工呼吸器の世界市場レポート2020 Market Analysis and Insights: Global Sub-acute Care Ventilators Market The global Sub-acute Care Ventilators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Sub-acute Care Ventilators Scope and Market Size The global Su…